PREVENTION OF ATHEROSCLEROSIS WITH REFERENCE TO OBESITY AND INADEQUATE NUTRITION AS RISK FACTORS FOR CARDIOVASCULAR DISEASES
Abstract
This paper will present information from relevant data sources related to the prevention of atherosclerosis with a focus on obesity and inadequate nutrition as a risk factor for CVD. The World Health Organization estimates that 17.9 million people die each year from cardiovascular diseases (CVDs), which is a third of the world's death toll. CVDs are not only the leading cause of death, but also of illness and disability, which indicates their great public health importance. Endothelial dysfunction is thought to be an early stage of atherosclerosis. Atherosclerosis also occurs in children under the age of 10, while the risk of atherosclerosis increases with age. There are over 300 factors associated with atherosclerosis and key complications, coronary heart disease and stroke. The most important of these are obesity, physical inactivity, hypertension, smoking, inadequate nutrition, abnormal lipids, heredity, metabolic syndrome, diabetes and psychosocial factors.
References
WHO. Cardiovaskulardiseases (CVDs). Available at: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)>
Marčeta E, Milić P. Risk factors for cardiovascular diseases. Zdravstvena zaštita 2018; 47(2):34-52.
Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S. Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease. CircRes 2016; 118(4):535–46.
Šumarac-Dumanović M. Is obesity a disease? Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma „Zlatibor“ 2017; 22(67):9-20.
Frostegård J. Immunity, atherosclerosis and cardiovascular disease. BMC Med 2013; 11:117.
Sun LY, Lee EW, Zahra A, Park JH. Risk Factors of Cardiovascular Disease and Their Related Socio-Economical, Environmental and Health Behavioral Factors: Focused on Low-Middle Income Countries - A Narrative Review Article. Iran J Public Health 2015; 44(4):435-44.
Vinereanu D. Risk factors for atherosclerotic disease: present and future. Herz 2006;31 (Suppl 3):5-24.
Leopold JA. Antioxidants and coronary artery disease: from pathophysiology to preventive therapy. CoronArtery Dis2015;26(2):176–83.
da LuzGiroldo M, VillelaBaroncini LA, Champoski AF, Carla A, Biazon B, Isolane A, Musial DC, Précoma DB. Householdcardiovascularscreening in adolescents from high-riskfamilies. Atherosclerosis 2013; 226(1):286-90.
Sandkamp M, Funke H, Schulte H, Köhler E, Assmann G. Lipoprotein (a) is an indipendent risc factor for myocardial infarction in young age. ClinChem 1990; 36(1):20-3.
Institute of Public Health of Serbia „Dr Milan Jovanović Batut”. Incidence and mortality of acute coronary syndrome in Serbia. Belgrade: Institute of Public Health of Serbia „Dr Milan Jovanović Batut”; 2014.
Agha M, Agha R. The rising prevalence of obesity: part A: impact on public health. Int J Surg Oncol (NY) 2017; 2(7): e17.
Piché ME, Tchernof A, Després JP. Obesity Phenotypes, Diabetes, and Cardiovascular Diseases. Circ Res 2020; 126(11):1477-500.
Jellinger PS, Mehta AE, Smith DA, Handelsman Y, Ganda O, Rodbard HW, et al. American Association of Clinical Endocrinologists’ Guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Pract 2012; 18:1-78.
Rashid S, Genest J. Effect of obesity on high-density lipoprotein metabolism. Obesity 2007; 15:2875-88.
Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 2013; 5:1218-40.
WHO: Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. Geneva: WHO TecnicalReportSeries 894; 2000.
Lovren F, Teoh H, Verma S. Obesity and atherosclerosis: mechanistic insights. Can J Cardiol 2015; 31(2):177-83.
Fitzgibbons TP, Czech MP. Emerging evidence for beneficial macrophage functions in atherosclerosis and obesity-induced insulin resistance. J Mol Med (Berl) 2016; 94(3):267-75.
Salas-Salvadó J, Becerra-Tomás N, García-Gavilán JF, Bulló M, Barrubés L. Mediterranean Diet and Cardiovascular Disease Prevention: What Do We Know? Prog Cardiovasc Dis 2018; 61(1):62-7.
Mladenović I, Mladenović D. Nutritive characteristics, physiological effects and health importance of dietary fiber. Zdravstvena zaštita 2020; 49(1):47-53.
Riccardi G, Giosuè A, Calabrese I, Vaccaro O. Dietary recommendations for prevention of atherosclerosis. Cardiovasc Res 2021; Jul 6;cvab173. Epubaheadof print.
Tuso P, Stoll SR, Li WW. A plant-based diet, atherogenesis, and coronary artery disease prevention. Perm J 2015;19(1):62-7.
Yang X, He T, Han S, Zhang X, Sun Y, Xing Y, Shang H. The Role of Traditional Chinese Medicine in the Regulation of Oxidative Stress in Treating Coronary Heart Disease. Oxid Med Cell Longev 2019; 2019:3231424.
Martin L, Oepen J, Reinehr T, Wabitsch M, Claussnitzer G, Waldeck E, et al. Ethnicity and cardiovascular risk factors: evaluation of 40,921 normal-weight, overweight or obese children and adolescents living in Central Europe. Int J Obes (Lond) 2015; 39(1):45-51.
Martínez-González MA, Gea A, Ruiz-Canela M. The Mediterranean Diet and Cardiovascular Health. Circ Res 2019; 124(5):779-98.
Centers for Disease Control and Prevention. State Indicator Report on Fruits and Vegetables, 2013. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Department of Health and Human Services; 2013.
Ministarstvo zdravlja. Prevencija kardiovaskularnih bolesti. Nacionalni vodič u kardiologiji. Podgorica: Ministarstvo zdravlja; 2012.
Wannamethee SG, Schaper AG. Physical activity in the prevention of cardiovascular diesase: an epidemiological perspective. Sports Med 2001; 31:101-14.